Income Statement Simulations Plus

Stocks

SLP

US8292141053

Advanced Medical Equipment & Technology

Delayed Nasdaq 23:00:00 05/10/2026 +03			5-day change	1st Jan Change
18.50 ^USD	0.00%		+0.05%	+1.48%

10-08	Simulations Plus, Inc. Announces Funded Partnership With Global Pharmaceutical Company To Advance AI-Enabled QSP Model Development With Turin	CI
10-06	Simulations Plus, Inc. Announces Management Changes, Effective October 6, 2026	CI

e6d25ac.ZopmCBc8OC_-hDGHvqKK21Tcl8WoqHR80rXrny8bNJY.NswVWllRD0vGt2TJ8db-oguU-pLg3DlFn_m8-lc2X8c83RVvWXV_RpfMdA

Published financial data: SIMULATIONS PLUS

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: August	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	46.47M	53.91M	59.58M	70.01M	79.18M
Total Revenues	46.47M	53.91M	59.58M	70.01M	79.18M
Cost of Goods Sold, Total	10.6M	10.82M	11.63M	26.86M	32.96M
Gross Profit	35.87M	43.08M	47.95M	43.15M	46.22M
Selling General & Admin Expenses, Total	20.57M	24.96M	30.92M	28.67M	32.14M
R&D Expenses	4.05M	3.21M	4.5M	5.75M	6.88M
Other Operating Expenses, Total	24.61M	28.17M	35.42M	34.42M	39.03M
Operating Income	11.25M	14.91M	12.52M	8.73M	7.19M
Interest Expense, Total	-22K	-	-	-	-
Interest And Investment Income	201K	717K	4.13M	4.38M	722K
Net Interest Expenses	179K	717K	4.13M	4.38M	722K
Currency Exchange Gains (Loss)	139K	-231K	-475K	386K	13K
EBT, Excl. Unusual Items	11.57M	15.4M	16.18M	13.49M	7.93M
Restructuring Charges	-	-	-	-	-700K
Merger & Related Restructuring Charges	-	-	-3.3M	-2.6M	-
Impairment of Goodwill	-	-	-	-	-51.63M
Gain (Loss) On Sale Of Investments	-	-	-	-120K	-
Gain (Loss) On Sale Of Assets	-	1K	-6K	-	-23K
Asset Writedown	-	-	-500K	-	-25.59M
Other Unusual Items	-486K	-283K	-680K	1.64M	640K
EBT, Incl. Unusual Items	11.08M	15.12M	11.7M	12.41M	-69.38M
Income Tax Expense	1.3M	2.63M	1.73M	2.46M	-4.66M
Earnings From Continuing Operations	9.78M	12.48M	9.96M	9.95M	-64.72M
Net Income to Company	9.78M	12.48M	9.96M	9.95M	-64.72M
Net Income - (IS)	9.78M	12.48M	9.96M	9.95M	-64.72M
Net Income to Common Incl Extra Items	9.78M	12.48M	9.96M	9.95M	-64.72M
Net Income to Common Excl. Extra Items	9.78M	12.48M	9.96M	9.95M	-64.72M
Per Share Items
Net EPS - Basic	0.49	0.62	0.5	0.5	-3.22
Basic EPS - Continuing Operations	0.49	0.62	0.5	0.5	-3.22
Basic Weighted Average Shares Outstanding	20.04M	20.2M	20.08M	19.99M	20.1M
Net EPS - Diluted	0.47	0.6	0.49	0.49	-3.22
Diluted EPS - Continuing Operations	0.47	0.6	0.49	0.49	-3.22
Diluted Weighted Average Shares Outstanding	20.74M	20.75M	20.46M	20.3M	20.1M
Normalized Basic EPS	0.36	0.48	0.5	0.42	0.25
Normalized Diluted EPS	0.35	0.46	0.49	0.42	0.25
Dividend Per Share	0.24	0.24	0.24	0.24	-
Payout Ratio	49.18	38.82	48.28	48.18	-
Supplemental Items
EBITDA	13.44M	17.28M	14.86M	12.3M	12.3M
EBITA	13.2M	16.91M	14.52M	12.03M	11.89M
EBIT	11.25M	14.91M	12.52M	8.73M	7.19M
EBITDAR	14.1M	17.88M	15.36M	12.8M	12.8M
Total Revenues (As Reported)	-	53.91M	59.58M	70.01M	79.18M
Effective Tax Rate - (Ratio)	11.75	17.41	14.83	19.8	6.72
Current Domestic Taxes	1.76M	3.13M	3.69M	4.03M	688K
Current Foreign Taxes	166K	-228K	144K	3K	108K
Total Current Taxes	1.93M	2.9M	3.83M	4.04M	796K
Deferred Domestic Taxes	-628K	-269K	-2.1M	-1.58M	-5.46M
Total Deferred Taxes	-628K	-269K	-2.1M	-1.58M	-5.46M
Normalized Net Income	7.23M	9.62M	10.11M	8.43M	4.95M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Marketing Expenses	60K	200K	-	-	-
Selling and Marketing Expenses	-	-	-	8.92M	11.9M
General and Administrative Expenses	-	-	-	19.75M	20.24M
Research And Development Expense From Footnotes	5.45M	4.41M	6M	7.85M	9.98M
Net Rental Expense, Total	655K	600K	500K	500K	500K
Imputed Operating Lease Interest Expense	105K	-	-	-	-
Imputed Operating Lease Depreciation	550K	-	-	-	-
Stock-Based Comp., Other (Total)	2.75M	3.04M	4.83M	6.54M	6.35M
Total Stock-Based Compensation	2.75M	3.04M	4.83M	6.54M	6.35M

Fiscal Period: August	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	36.98M	51.57M	57.52M	10.31M	30.85M
Short Term Investments	86.62M	76.67M	57.94M	9.94M	1.5M
Total Cash And Short Term Investments	124M	128M	115M	20.26M	32.35M
Accounts Receivable, Total	13M	15.49M	12.9M	9.14M	14.62M
Total Receivables	13M	15.49M	12.9M	9.14M	14.62M
Prepaid Expenses	1.7M	1.68M	1.2M	7.75M	2.8M
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	1.01M	1.39M	804K	2.2M	1.78M
Total Current Assets	139M	147M	130M	39.34M	51.55M
Gross Property Plant And Equipment	3.53M	2.7M	2.58M	2.44M	1.86M
Accumulated Depreciation	-412K	-648K	-660K	-603K	-577K
Net Property Plant And Equipment	3.11M	2.05M	1.92M	1.84M	1.29M
Goodwill	12.92M	12.92M	19.1M	96.08M	43.72M
Other Intangibles, Total	24.58M	26.18M	32.85M	58.84M	29.21M
Deferred Tax Assets Long-Term	-	-	1.44M	-	4.77M
Other Long-Term Assets, Total	51K	439K	425K	542K	1.4M
Total Assets	180M	188M	186M	197M	132M
Liabilities
Accounts Payable, Total	387K	225K	144K	602K	470K
Accrued Expenses, Total	5.6M	4.18M	5.05M	6.56M	3.35M
Current Portion of Leases	382K	461K	442K	475K	206K
Unearned Revenue Current, Total	5.2M	2.86M	3.1M	2M	2.7M
Other Current Liabilities	-	-	3.25M	2.44M	-
Total Current Liabilities	11.57M	7.74M	11.99M	12.07M	6.72M
Long-Term Leases	896K	943K	755K	531K	410K
Unearned Revenue Non Current	-	-	-	-	-
Deferred Tax Liability Non Current	1.73M	1.46M	-	1.61M	-
Other Non Current Liabilities	-	-	3.33M	-	-
Total Liabilities	14.2M	10.13M	16.07M	14.21M	7.14M
Common Stock, Total	133M	139M	145M	152M	20K
Additional Paid In Capital	-	-	-	-	159M
Retained Earnings	32.41M	40.04M	25.2M	30.35M	-34.36M
Comprehensive Income and Other	-43K	-308K	-141K	-251K	-271K
Total Common Equity	166M	178M	170M	182M	125M
Total Equity	166M	178M	170M	182M	125M
Total Liabilities And Equity	180M	188M	186M	197M	132M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	20.15M	20.3M	19.94M	20.07M	20.14M
ECS Total Common Shares Outstanding	20.14M	20.26M	19.94M	20.05M	20.14M
Book Value / Share	8.23	8.8	8.53	9.1	6.2
Tangible Book Value	128M	139M	118M	27.51M	51.87M
Tangible Book Value Per Share	6.37	6.87	5.92	1.37	2.58
Total Debt	1.28M	1.4M	1.2M	1.01M	616K
Net Debt	-122M	-127M	-114M	-19.25M	-31.74M
Debt Equivalent Oper. Leases	5.24M	4.8M	4M	4M	4M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	935K	1.27M	1.17M	1.4M	1.45M
Full Time Employees	135	157	192	243	212
Part Time Employees	11	6	5	4	1
Accumulated Allowance for Doubtful Accounts (Supple)	78K	12K	46K	149K	187K

Fiscal Period: August	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	9.78M	12.48M	9.96M	9.95M	-64.72M
Depreciation & Amortization - CF	246K	374K	340K	265K	411K
Amortization of Goodwill and Intangible Assets - (CF)	1.94M	2M	2M	3.3M	4.7M
Depreciation & Amortization, Total	2.19M	2.37M	2.34M	3.56M	5.11M
Amortization of Deferred Charges, Total - (CF)	1.4M	1.2M	1.5M	2.1M	3.1M
(Gain) Loss From Sale Of Asset	-	-	6K	-	23K
(Gain) Loss on Sale of Investments - (CF)	2.35M	1.68M	-1.13M	-1.12M	-64K
Asset Writedown & Restructuring Costs	-	-	500K	-	77.22M
Stock-Based Compensation (CF)	2.75M	3.04M	4.83M	6.54M	6.35M
Other Operating Activities, Total	-243K	-252K	-1.25M	-3.51M	-6.32M
Change In Accounts Receivable	-2.49M	-3.94M	4.1M	3.13M	-581K
Change In Accounts Payable	39K	-162K	-81K	-477K	-132K
Change in Unearned Revenues	210K	2.21M	176K	-2.56M	700K
Change In Income Taxes	-42K	-379K	580K	-1.39M	420K
Change in Other Net Operating Assets	3.25M	-356K	331K	-2.91M	-2.99M
Cash from Operations	19.2M	17.9M	21.86M	13.32M	18.13M
Capital Expenditure	-1.63M	-819K	-453K	-566K	-713K
Cash Acquisitions	-	-	-8.22M	-98.77M	-227K
Sale (Purchase) of Intangible assets	-2.95M	-3.15M	-3.82M	-3.74M	-3.01M
Investment in Marketable and Equity Securities, Total	-22.17M	8.28M	19.86M	49.11M	8.51M
Other Investing Activities, Total	-	-	-	-	-1M
Cash from Investing	-26.74M	4.3M	7.37M	-53.97M	3.56M
Issuance of Common Stock	1.46M	891K	1.54M	731K	430K
Repurchase of Common Stock	-	-	-20M	-	-
Common Dividends Paid	-4.81M	-4.85M	-4.81M	-4.8M	-
Common & Preferred Stock Dividends Paid	-4.81M	-4.85M	-4.81M	-4.8M	-
Other Financing Activities, Total	-1.33M	-3.67M	-	-2.5M	-1.58M
Cash from Financing	-4.68M	-7.62M	-23.27M	-6.56M	-1.15M
Net Change in Cash	-12.22M	14.58M	5.96M	-47.21M	20.54M
Supplemental Items
Cash Income Tax Paid (Refund)	1.86M	3.23M	3.2M	5.69M	1.16M
Levered Free Cash Flow	12.3M	5.2M	20.14M	9.23M	10.15M
Unlevered Free Cash Flow	12.32M	5.2M	20.14M	9.23M	10.15M
Change In Net Working Capital	-3.52M	6.76M	-7.92M	4.13M	5.18M

Fiscal Period: August	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	4.04	5.06	4.18	2.85	2.74
Return on Total Capital	4.34	5.38	4.46	3.08	2.91
Return On Equity %	6.08	7.26	5.72	5.65	-42.13
Return on Common Equity	6.08	7.26	5.72	5.65	-42.13
Margin Analysis
Gross Profit Margin %	77.19	79.92	80.48	61.63	58.38
SG&A Margin	44.26	46.31	51.9	40.94	40.6
EBITDA Margin %	28.93	32.06	24.95	17.56	15.54
EBITA Margin %	28.4	31.37	24.38	17.18	15.02
EBIT Margin %	24.22	27.66	21.02	12.47	9.08
Income From Continuing Operations Margin %	21.05	23.16	16.72	14.22	-81.74
Net Income Margin %	21.05	23.16	16.72	14.22	-81.74
Net Avail. For Common Margin %	21.05	23.16	16.72	14.22	-81.74
Normalized Net Income Margin	15.56	17.85	16.97	12.04	6.26
Levered Free Cash Flow Margin	26.48	9.64	33.81	13.18	12.82
Unlevered Free Cash Flow Margin	26.51	9.64	33.81	13.18	12.82
Asset Turnover
Asset Turnover	0.27	0.29	0.32	0.37	0.48
Fixed Assets Turnover	20.75	20.87	30.01	37.27	50.66
Receivables Turnover (Average Receivables)	3.95	3.78	4.2	7.24	5.34
Short Term Liquidity
Current Ratio	12.04	18.98	10.88	3.26	7.67
Quick Ratio	11.8	18.58	10.71	2.44	6.98
Operating Cash Flow to Current Liabilities	1.66	2.31	1.82	1.1	2.7
Days Sales Outstanding (Average Receivables)	92.36	96.62	86.96	50.54	68.35
Average Days Payable Outstanding	12.71	10.32	5.79	5.08	5.94
Long Term Solvency
Total Debt/Equity	0.77	0.79	0.7	0.55	0.49
Total Debt / Total Capital	0.76	0.78	0.7	0.55	0.49
LT Debt/Equity	0.54	0.53	0.44	0.29	0.33
Long-Term Debt / Total Capital	0.54	0.52	0.44	0.29	0.33
Total Liabilities / Total Assets	7.89	5.38	8.64	7.23	5.41
EBIT / Interest Expense	511.5	-	-	-	-
EBITDA / Interest Expense	640.82	-	-	-	-
(EBITDA - Capex) / Interest Expense	566.86	-	-	-	-
Total Debt / EBITDA	0.09	0.08	0.08	0.08	0.05
Net Debt / EBITDA	-8.68	-7.09	-7.44	-1.5	-2.48
Total Debt / (EBITDA - Capex)	0.1	0.08	0.08	0.08	0.05
Net Debt / (EBITDA - Capex)	-9.81	-7.43	-7.66	-1.57	-2.63
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	11.73	16.01	10.52	17.52	13.09
Gross Profit, 1 Yr. Growth %	15.92	20.12	11.29	-10	7.11
EBITDA, 1 Yr. Growth %	-7.66	28.58	-15.47	-17.28	0.06
EBITA, 1 Yr. Growth %	-7.89	28.57	-15.61	-17.17	-1.16
EBIT, 1 Yr. Growth %	-13.47	32.51	-17.66	-30.29	-17.63
Earnings From Cont. Operations, 1 Yr. Growth %	4.82	27.61	-20.2	-0.07	-750.17
Net Income, 1 Yr. Growth %	4.82	27.61	-20.2	-0.07	-750.17
Normalized Net Income, 1 Yr. Growth %	-10.92	33.07	3.08	-16.62	-41.25
Diluted EPS Before Extra, 1 Yr. Growth %	-6	27.66	-18.33	0	-757.14
Accounts Receivable, 1 Yr. Growth %	23.64	18.67	-16.7	-10.44	-2.79
Net Property, Plant and Equip., 1 Yr. Growth %	128.13	-34.1	-6.53	-4.12	-30.02
Total Assets, 1 Yr. Growth %	6.86	4.67	-1.21	5.66	-32.9
Tangible Book Value, 1 Yr. Growth %	8.6	8.47	-15.14	-76.7	88.54
Common Equity, 1 Yr. Growth %	6.25	7.52	-4.61	7.29	-31.59
Cash From Operations, 1 Yr. Growth %	75.98	-6.79	22.1	-39.06	36.08
Capital Expenditures, 1 Yr. Growth %	604.33	-49.66	-44.69	24.94	25.97
Levered Free Cash Flow, 1 Yr. Growth %	76	-57.77	274.08	-54.17	9.98
Unlevered Free Cash Flow, 1 Yr. Growth %	76.19	-57.82	274.08	-54.17	9.98
Dividend Per Share, 1 Yr. Growth %	0	0	0	0	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	16.96	13.85	13.23	13.96	15.28
Gross Profit, 2 Yr. CAGR %	19.91	18	15.62	0.08	-1.82
EBITDA, 2 Yr. CAGR %	5.41	13.72	5.16	-16.38	-9.02
EBITA, 2 Yr. CAGR %	5.15	13.6	5.09	-16.39	-9.52
EBIT, 2 Yr. CAGR %	2.8	13.35	5.5	-24.24	-24.22
Earnings From Cont. Operations, 2 Yr. CAGR %	6.76	15.66	0.91	-10.7	154.89
Net Income, 2 Yr. CAGR %	6.76	15.66	0.91	-10.7	154.89
Normalized Net Income, 2 Yr. CAGR %	4.16	15.26	18.25	-7.29	-30.01
Diluted EPS Before Extra, 2 Yr. CAGR %	-1.05	9.54	2.11	-9.63	156.35
Accounts Receivable, 2 Yr. CAGR %	25.46	21.36	-0.58	-23.19	19.7
Net Property, Plant and Equip., 2 Yr. CAGR %	202.13	22.61	-21.52	-5.33	-18.08
Total Assets, 2 Yr. CAGR %	99.55	5.76	1.69	2.17	-15.8
Tangible Book Value, 2 Yr. CAGR %	202.4	8.54	-4.06	-55.53	-33.72
Common Equity, 2 Yr. CAGR %	109.75	6.88	1.27	1.17	-14.33
Cash From Operations, 2 Yr. CAGR %	28.46	28.08	6.68	-13.74	-8.93
Capital Expenditures, 2 Yr. CAGR %	243.36	88.29	-47.23	-16.87	25.46
Levered Free Cash Flow, 2 Yr. CAGR %	30.94	-7.83	27.94	30.94	-29
Unlevered Free Cash Flow, 2 Yr. CAGR %	31.01	-7.83	27.87	30.94	-29
Dividend Per Share, 2 Yr. CAGR %	0	0	0	0	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	16.13	16.64	12.73	14.64	13.67
Gross Profit, 3 Yr. CAGR %	18.28	19.98	15.72	6.36	2.37
EBITDA, 3 Yr. CAGR %	4.68	12.63	3.6	-2.93	-11.23
EBITA, 3 Yr. CAGR %	4.45	12.32	3.49	-2.93	-11.59
EBIT, 3 Yr. CAGR %	3	11.88	2.58	-8.11	-22.1
Earnings From Cont. Operations, 3 Yr. CAGR %	3.07	13.3	2.2	0.58	73.08
Net Income, 3 Yr. CAGR %	3.07	13.3	2.2	0.58	73.08
Normalized Net Income, 3 Yr. CAGR %	3.98	13.02	11.77	5.25	-20.37
Diluted EPS Before Extra, 3 Yr. CAGR %	-2.04	7.72	-0.67	1.4	75.08
Accounts Receivable, 3 Yr. CAGR %	20.13	23.31	7.05	-11.21	-1.91
Net Property, Plant and Equip., 3 Yr. CAGR %	110.21	81.86	12.01	-16.1	-14.4
Total Assets, 3 Yr. CAGR %	60.81	60.93	3.38	3	-11.19
Tangible Book Value, 3 Yr. CAGR %	165.69	114.86	-0.01	-40.14	-28.03
Common Equity, 3 Yr. CAGR %	73.17	67.87	2.9	3.24	-11.2
Cash From Operations, 3 Yr. CAGR %	27.4	15.44	26.05	-11.48	0.42
Capital Expenditures, 3 Yr. CAGR %	107.05	81.05	25.17	-29.67	-4.52
Levered Free Cash Flow, 3 Yr. CAGR %	13.79	-10.21	48.77	-9.14	23.54
Unlevered Free Cash Flow, 3 Yr. CAGR %	13.83	-10.21	48.77	-9.17	23.54
Dividend Per Share, 3 Yr. CAGR %	0	0	0	0	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	18.4	17.43	14.96	15.56	13.74
Gross Profit, 5 Yr. CAGR %	18.47	19.3	17.21	11.58	8.36
EBITDA, 5 Yr. CAGR %	10.44	11.74	4.87	0.33	-1.65
EBITA, 5 Yr. CAGR %	10.57	11.6	4.64	0.16	-1.92
EBIT, 5 Yr. CAGR %	9.25	10.91	3.99	-3.89	-9.13
Earnings From Cont. Operations, 5 Yr. CAGR %	14.59	16.62	2.2	3.01	47.3
Net Income, 5 Yr. CAGR %	14.59	16.62	2.2	3.01	47.3
Normalized Net Income, 5 Yr. CAGR %	9.84	11.69	9.47	4.81	-7.32
Diluted EPS Before Extra, 5 Yr. CAGR %	10.14	12.7	-0.4	0.41	45.14
Accounts Receivable, 5 Yr. CAGR %	28.55	22.87	11.46	2.04	6.81
Net Property, Plant and Equip., 5 Yr. CAGR %	64.77	47.78	41.74	40.06	-1.17
Total Assets, 5 Yr. CAGR %	45.27	37.37	33.87	34.19	-4.77
Tangible Book Value, 5 Yr. CAGR %	74.59	244.8	76.78	14.42	-15.17
Common Equity, 5 Yr. CAGR %	48.79	47.19	39.73	37.09	-4.37
Cash From Operations, 5 Yr. CAGR %	28.81	21.08	18.67	2.74	10.68
Capital Expenditures, 5 Yr. CAGR %	110.76	36.01	19.84	32.61	25.28
Levered Free Cash Flow, 5 Yr. CAGR %	38.8	1.34	19.25	5.16	10.67
Unlevered Free Cash Flow, 5 Yr. CAGR %	38.84	1.25	19.25	5.16	10.67
Dividend Per Share, 5 Yr. CAGR %	3.71	3.71	0	0	-